agilon health (AGL) analyst forecast and price target
Analyst forecast
Consensus of 15 analyst ratings
Based on 8 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Bernstein | Upgraded | Market Perform → Outperform | $125.00 from $86.00 | Sep 15, 2026 |
| JP Morgan | Maintained | Underweight | $85.00 from $31.00 | Aug 24, 2026 |
| Citigroup | Upgraded | Sell → Neutral | $115.00 from $105.00 | Aug 11, 2026 |
| Wells Fargo | Maintained | Overweight | $146.00 from $141.00 | Aug 11, 2026 |
| Barclays | Maintained | Equal-Weight | $111.00 from $81.00 | Aug 6, 2026 |
| Evercore ISI Group | Maintained | In-Line | $125.00 from $120.00 | Aug 6, 2026 |
| Benchmark | Maintained | Buy | $140.00 from $95.00 | Aug 6, 2026 |
| Truist Securities | Maintained | Hold | $112.00 from $67.00 | Aug 6, 2026 |
| Citigroup | Downgraded | Neutral → Sell | $105.00 from $80.00 | Jul 23, 2026 |
| Wells Fargo | Maintained | Overweight | $141.00 from $72.00 | Jul 13, 2026 |
| Barclays | Upgraded | Underweight → Equal-Weight | $81.00 | May 26, 2026 |
| Benchmark | Maintained | Buy | $95.00 from $13.00 | May 21, 2026 |
| Citigroup | Maintained | Neutral | $80.00 from $18.75 | May 15, 2026 |
| TD Cowen | Maintained | Hold | $55.00 from $17.00 | May 11, 2026 |
| Wells Fargo | Maintained | Overweight | $72.00 from $37.50 | May 8, 2026 |
| Deutsche Bank | Upgraded | Hold → Buy | $49.00 from $33.00 | May 7, 2026 |
| Baird | Maintained | Neutral | $35.00 from $20.00 | May 7, 2026 |
| Jefferies | Upgraded | Hold → Buy | $48.00 from $27.50 | May 7, 2026 |
| Evercore ISI Group | Maintained | In-Line | $32.00 from $16.00 | May 7, 2026 |
| JP Morgan | Downgraded | Neutral → Underweight | $21.00 | May 4, 2026 |
Frequently asked questions
What is the price target for AGL stock?
The average 12-month analyst price target for agilon health (AGL) is $119.88, with a high estimate of $146.00 and a low of $85.00, across 8 analysts.
Is AGL a buy, sell, or hold?
Analysts covering agilon health currently average a Hold rating: 5 buy, 9 hold and 1 sell, from 15 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for AGL?
The average price target of $119.88 implies 37.31% upside from the last price of $87.30.
What is the latest analyst rating on AGL?
On Sep 15, 2026, Bernstein upgraded agilon health to Outperform with a price target of $125.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.